Brain FDG-PET correlates of saccadic disorders in early PSP.

Atypical parkinsonism Eye movement analysis Fluorodeoxyglucose positron emission tomography Progressive supranuclear palsy

Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 07 03 2023
accepted: 13 06 2023
revised: 17 05 2023
medline: 21 9 2023
pubmed: 18 6 2023
entrez: 18 6 2023
Statut: ppublish

Résumé

New diagnostic criteria of Progressive Supranuclear Palsy (PSP) have highlighted the interest of Eye Movement Records (EMR) at the early stage of the disease. To investigate the metabolic brain correlates of ocular motor dysfunction using [18F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in early PSP. Retrospective observational descriptive study on longitudinal data with patients who underwent EMR and FDG-PET at the stage of suggestive and possible PSP according to Movement Disorders Society criteria. Longitudinal follow-up enables to confirm diagnosis of probable PSP. Using the Statistical Parametric Mapping software, we performed whole-brain voxel-based correlations between oculomotor variables and FDG-PET metabolism. Thirty-seven patients with early PSP who fulfilled criteria of probable PSP during the follow-up were included. Decrease in the gain of vertical saccades correlated with reduced metabolism in Superior Colliculi (SC). We also found a positive correlation between mean velocity of horizontal saccades and SC metabolism as well as dorsal nuclei in the pons. Finally, increase in horizontal saccades latencies correlated with decrease of posterior parietal metabolism. These findings suggest the early involvement of SC in saccadic dysfunction in the course of PSP.

Sections du résumé

BACKGROUND BACKGROUND
New diagnostic criteria of Progressive Supranuclear Palsy (PSP) have highlighted the interest of Eye Movement Records (EMR) at the early stage of the disease.
OBJECTIVES OBJECTIVE
To investigate the metabolic brain correlates of ocular motor dysfunction using [18F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in early PSP.
METHODS METHODS
Retrospective observational descriptive study on longitudinal data with patients who underwent EMR and FDG-PET at the stage of suggestive and possible PSP according to Movement Disorders Society criteria. Longitudinal follow-up enables to confirm diagnosis of probable PSP. Using the Statistical Parametric Mapping software, we performed whole-brain voxel-based correlations between oculomotor variables and FDG-PET metabolism.
RESULTS RESULTS
Thirty-seven patients with early PSP who fulfilled criteria of probable PSP during the follow-up were included. Decrease in the gain of vertical saccades correlated with reduced metabolism in Superior Colliculi (SC). We also found a positive correlation between mean velocity of horizontal saccades and SC metabolism as well as dorsal nuclei in the pons. Finally, increase in horizontal saccades latencies correlated with decrease of posterior parietal metabolism.
CONCLUSIONS CONCLUSIONS
These findings suggest the early involvement of SC in saccadic dysfunction in the course of PSP.

Identifiants

pubmed: 37330976
doi: 10.1007/s00415-023-11824-w
pii: 10.1007/s00415-023-11824-w
doi:

Substances chimiques

Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4841-4850

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Références

Litvan I, Agid Y, Calne D et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop*. Neurology 47:1–9. https://doi.org/10.1212/WNL.47.1.1
doi: 10.1212/WNL.47.1.1 pubmed: 8710059
Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy. Nuchal dystonia and dementia. Arch Neurol 10:333–359. https://doi.org/10.1001/archneur.1964.00460160003001
doi: 10.1001/archneur.1964.00460160003001 pubmed: 14107684
Respondek G, Kurz C, Arzberger T et al (2017) Which ante mortem clinical features predict progressive supranuclear palsy pathology? Mov Disord 32:995–1005. https://doi.org/10.1002/mds.27034
doi: 10.1002/mds.27034 pubmed: 28500752 pmcid: 5543934
Respondek G, Stamelou M, Kurz C et al (2014) The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Mov Disord 29:1758–1766. https://doi.org/10.1002/mds.26054
doi: 10.1002/mds.26054 pubmed: 25370486
Marx S, Respondek G, Stamelou M et al (2012) Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson’s disease. Front Behav Neurosci. https://doi.org/10.3389/fnbeh.2012.00088
doi: 10.3389/fnbeh.2012.00088 pubmed: 23248593 pmcid: 3521127
Shaikh AG, Factor SA, Juncos JL (2017) Saccades in progressive supranuclear palsy-maladapted, irregular, curved, and slow. Mov Disord Clin Pract 4:671–681. https://doi.org/10.1002/mdc3.12491
doi: 10.1002/mdc3.12491 pubmed: 29333474 pmcid: 5764187
Rivaud-Pechoux S, Vidailhet M, Gallouedec G et al (2000) Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology 54:1029–1032. https://doi.org/10.1212/WNL.54.5.1029
doi: 10.1212/WNL.54.5.1029 pubmed: 10720270
Höglinger GU, Respondek G, Stamelou M et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria: MDS Clinical Diagnostic Criteria for PSP. Mov Disord 32:853–864. https://doi.org/10.1002/mds.26987
doi: 10.1002/mds.26987 pubmed: 28467028 pmcid: 5516529
Garbutt S (2012) Saccade abnormalities in autopsy-confirmed frontotemporal lobar degeneration and alzheimer disease. Arch Neurol 69:509. https://doi.org/10.1001/archneurol.2011.1021
doi: 10.1001/archneurol.2011.1021 pubmed: 22491196 pmcid: 3423186
Groschel K, Kastrup A, Litvan I et al (2006) Penguins and hummingbirds: midbrain atrophy in progressive supranuclear palsy. Neurology 66:949–950. https://doi.org/10.1212/01.wnl.0000203342.77115.bf
doi: 10.1212/01.wnl.0000203342.77115.bf pubmed: 16567726
Amtage F, Maurer C, Hellwig S et al (2014) Functional correlates of vertical gaze palsy and other ocular motor deficits in PSP: an FDG-PET study. Parkinsonism Relat Disord 20:898–906. https://doi.org/10.1016/j.parkreldis.2014.05.013
doi: 10.1016/j.parkreldis.2014.05.013 pubmed: 24935235
Verger A, Grimaldi S, Ribeiro M et al (2021) Single photon emission computed tomography/positron emission tomography molecular imaging for parkinsonism: a fast-developing field. Ann Neurol 90:711–719. https://doi.org/10.1002/ana.26187
doi: 10.1002/ana.26187 pubmed: 34338333 pmcid: 9291534
Grimm M-J, Respondek G, Stamelou M et al (2019) How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy. Mov Disord 34:1228–1232. https://doi.org/10.1002/mds.27666
doi: 10.1002/mds.27666 pubmed: 30884545 pmcid: 6699888
Buch KA, Bouffard MA, Kardon RH et al (2022) Clinical correlation between vertical gaze palsy and midbrain volume in progressive supranuclear palsy. J Neuroophthalmol 42:246–250. https://doi.org/10.1097/WNO.0000000000001393
doi: 10.1097/WNO.0000000000001393 pubmed: 34417776
Jaillard A, Petyt G, Morelle M (2016) [18F]-Fdg pet identified superior colliculi hypometabolism in progressive supranuclear palsy. J Alzheimers Dis Parkinsonism. https://doi.org/10.4172/2161-0460.1000278
doi: 10.4172/2161-0460.1000278
Bhidayasiri R, Riley DE, Somers JT et al (2001) Pathophysiology of slow vertical saccades in progressive supranuclear palsy. Neurology 57:2070–2077. https://doi.org/10.1212/wnl.57.11.2070
doi: 10.1212/wnl.57.11.2070 pubmed: 11739828
Soetedjo R, Kaneko CRS, Fuchs AF (2002) Evidence that the superior colliculus participates in the feedback control of saccadic eye movements. J Neurophysiol 87:679–695. https://doi.org/10.1152/jn.00886.2000
doi: 10.1152/jn.00886.2000 pubmed: 11826037
Hanes DP, Smith MK, Optican LM et al (2005) Recovery of saccadic dysmetria following localized lesions in monkey superior colliculus. Exp Brain Res 160:312–325. https://doi.org/10.1007/s00221-004-2013-z
doi: 10.1007/s00221-004-2013-z pubmed: 15448959
Terao Y, Fukuda H, Ugawa Y et al (2013) New perspectives on the pathophysiology of Parkinson’s disease as assessed by saccade performance: a clinical review. Clin Neurophysiol 124:1491–1506. https://doi.org/10.1016/j.clinph.2013.01.021
doi: 10.1016/j.clinph.2013.01.021 pubmed: 23499161
Blekher T, Weaver M, Rupp J et al (2009) Multiple step pattern as a biomarker in Parkinson disease. Parkinsonism Relat Disord 15:506–510. https://doi.org/10.1016/j.parkreldis.2009.01.002
doi: 10.1016/j.parkreldis.2009.01.002 pubmed: 19211293 pmcid: 2872983
Horn AKE (2006) The reticular formation. Prog Brain Res 151:127–155. https://doi.org/10.1016/S0079-6123(05)51005-7
doi: 10.1016/S0079-6123(05)51005-7 pubmed: 16221588
Büttner-Ennever JA, Horn AK, Henn V et al (1999) Projections from the superior colliculus motor map to omnipause neurons in monkey. J Comp Neurol 413:55–67. https://doi.org/10.1002/(sici)1096-9861(19991011)413:1%3c55::aid-cne3%3e3.0.co;2-k
doi: 10.1002/(sici)1096-9861(19991011)413:1<55::aid-cne3>3.0.co;2-k pubmed: 10464369
Stanton GB, Goldberg ME, Bruce CJ (1988) Frontal eye field efferents in the macaque monkey: II. Topography of terminal fields in midbrain and pons. J Comp Neurol 271:493–506. https://doi.org/10.1002/cne.902710403
doi: 10.1002/cne.902710403 pubmed: 2454971
Shinoda Y, Sugiuchi Y, Takahashi M et al (2011) Neural substrate for suppression of omnipause neurons at the onset of saccades. Ann N Y Acad Sci 1233:100–106. https://doi.org/10.1111/j.1749-6632.2011.06171.x
doi: 10.1111/j.1749-6632.2011.06171.x pubmed: 21950982
Sparks D, Rohrer WH, Zhang Y (2000) The role of the superior colliculus in saccade initiation: a study of express saccades and the gap effect. Vis Res 40:2763–2777. https://doi.org/10.1016/s0042-6989(00)00133-4
doi: 10.1016/s0042-6989(00)00133-4 pubmed: 10960650
Bisley JW, Goldberg ME (2010) Attention, intention, and priority in the parietal lobe. Annu Rev Neurosci 33:1–21. https://doi.org/10.1146/annurev-neuro-060909-152823
doi: 10.1146/annurev-neuro-060909-152823 pubmed: 20192813 pmcid: 3683564
Pierrot-Deseilligny C, Rosa A, Masmoudi K et al (1991) Saccade deficits after a unilateral lesion affecting the superior colliculus. J Neurol Neurosurg Psychiatry 54:1106–1109. https://doi.org/10.1136/jnnp.54.12.1106
doi: 10.1136/jnnp.54.12.1106 pubmed: 1783927 pmcid: 1014690
Ghika J, Tennis M, Growdon J et al (1995) Environment-driven responses in progressive supranuclear palsy. J Neurol Sci 130:104–111. https://doi.org/10.1016/0022-510X(95)00015-T
doi: 10.1016/0022-510X(95)00015-T pubmed: 7650525
Shires J, Joshi S, Basso MA (2010) Shedding new light on the role of the basal ganglia-superior colliculus pathway in eye movements. Curr Opin Neurobiol 20:717–725. https://doi.org/10.1016/j.conb.2010.08.008
doi: 10.1016/j.conb.2010.08.008 pubmed: 20829033 pmcid: 3008502
Jamadar SD, Fielding J, Egan GF (2013) Quantitative meta-analysis of fMRI and PET studies reveals consistent activation in fronto-striatal-parietal regions and cerebellum during antisaccades and prosaccades. Front Psychol. https://doi.org/10.3389/fpsyg.2013.00749
doi: 10.3389/fpsyg.2013.00749 pubmed: 24137150 pmcid: 3797465
Kang SS, Dionisio DP, Sponheim SR (2011) Abnormal mechanisms of antisaccade generation in schizophrenia patients and unaffected biological relatives of schizophrenia patients. Psychophysiology 48:350–361. https://doi.org/10.1111/j.1469-8986.2010.01074.x
doi: 10.1111/j.1469-8986.2010.01074.x pubmed: 20636287 pmcid: 2994980

Auteurs

G Pin (G)

Department of Neurology and Neuropsychology, and CMMR PACA Ouest, CHU Timone, Assistance Publique Hôpitaux de Marseille, Marseille, France. gregoire.pin@ap-hm.fr.

J Labouré (J)

Department of Neurology and Neuropsychology, and CMMR PACA Ouest, CHU Timone, Assistance Publique Hôpitaux de Marseille, Marseille, France.

E Guedj (E)

Department of Nuclear Medecine, CHU Timone, Assistance Publique Hôpitaux de Marseille, Marseille, France.
CERIMED, Aix-Marseille University, Marseille, France.
Aix-Marseille University, UMR 7249, CNRS, Centrale Marseille, Institut Fresnel, Marseille, France.

O Felician (O)

Department of Neurology and Neuropsychology, and CMMR PACA Ouest, CHU Timone, Assistance Publique Hôpitaux de Marseille, Marseille, France.

S Grimaldi (S)

Department of Neurology and Movement Disorders, CHU Timone, Assistance Publique Hôpitaux de Marseille, Marseille, France.

J P Azulay (JP)

Department of Neurology and Movement Disorders, CHU Timone, Assistance Publique Hôpitaux de Marseille, Marseille, France.

M Ceccaldi (M)

Department of Neurology and Neuropsychology, and CMMR PACA Ouest, CHU Timone, Assistance Publique Hôpitaux de Marseille, Marseille, France.

L Koric (L)

Department of Neurology and Neuropsychology, and CMMR PACA Ouest, CHU Timone, Assistance Publique Hôpitaux de Marseille, Marseille, France.
Aix-Marseille University, UMR 7249, CNRS, Centrale Marseille, Institut Fresnel, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH